全文获取类型
收费全文 | 333146篇 |
免费 | 80094篇 |
国内免费 | 12339篇 |
专业分类
耳鼻咽喉 | 4635篇 |
儿科学 | 8500篇 |
妇产科学 | 4130篇 |
基础医学 | 35538篇 |
口腔科学 | 12396篇 |
临床医学 | 57908篇 |
内科学 | 66829篇 |
皮肤病学 | 12249篇 |
神经病学 | 30181篇 |
特种医学 | 11896篇 |
外国民族医学 | 61篇 |
外科学 | 44525篇 |
综合类 | 34751篇 |
现状与发展 | 88篇 |
一般理论 | 35篇 |
预防医学 | 30281篇 |
眼科学 | 7655篇 |
药学 | 25429篇 |
207篇 | |
中国医学 | 11962篇 |
肿瘤学 | 26323篇 |
出版年
2024年 | 880篇 |
2023年 | 6876篇 |
2022年 | 6076篇 |
2021年 | 11516篇 |
2020年 | 15700篇 |
2019年 | 16903篇 |
2018年 | 19680篇 |
2017年 | 21238篇 |
2016年 | 22057篇 |
2015年 | 24840篇 |
2014年 | 29323篇 |
2013年 | 31622篇 |
2012年 | 21090篇 |
2011年 | 21935篇 |
2010年 | 25251篇 |
2009年 | 22517篇 |
2008年 | 15947篇 |
2007年 | 14017篇 |
2006年 | 14582篇 |
2005年 | 12012篇 |
2004年 | 8910篇 |
2003年 | 8727篇 |
2002年 | 7245篇 |
2001年 | 7350篇 |
2000年 | 5799篇 |
1999年 | 5154篇 |
1998年 | 3930篇 |
1997年 | 3865篇 |
1996年 | 3373篇 |
1995年 | 2949篇 |
1994年 | 2192篇 |
1993年 | 1584篇 |
1992年 | 1559篇 |
1991年 | 1321篇 |
1990年 | 1113篇 |
1989年 | 1013篇 |
1988年 | 961篇 |
1987年 | 782篇 |
1986年 | 657篇 |
1985年 | 544篇 |
1984年 | 376篇 |
1983年 | 395篇 |
1982年 | 283篇 |
1981年 | 238篇 |
1980年 | 152篇 |
1979年 | 112篇 |
1978年 | 154篇 |
1977年 | 125篇 |
1976年 | 106篇 |
1974年 | 83篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
Objective
The aim of the study was to estimate the effect of the state-based reinsurance programs through the section 1332 State Innovation Waivers on health insurance marketplace premiums and insurer participation.Data Source
2015 to 2022 Robert Wood Johnson Foundation Health Insurance Exchange Compare Datasets.Study Design
An event study difference-in-differences (DD) model separately for each year of implementation and a synthetic control method (SCM) are used to estimate year-by-year effects following program implementation.Data Collection/Extraction Methods
Not applicable.Principal Findings
Reinsurance programs were associated with a decline in premiums in the first year of implementation by 10%–13%, 5%–19%, and 11%–17% for bronze, silver, and gold plans (p < 0.05). There is a trend of sustained declines especially for states that implemented their programs in 2019 and 2020. The SCM analyses suggest some effect heterogeneity across states but also premium declines across most states. There is no evidence that reinsurance programs affected insurer participation.Conclusion
State-based reinsurance programs have the potential to improve the affordability of health insurance coverage. However, reinsurance programs do not appear to have had an effect on insurer participation, highlighting the need for policy makers to consider complementary strategies to encourage insurer participation. 相似文献2.
3.
4.
5.
6.
7.
8.
目的 探讨右美托咪定联合综合体温保护对腔镜手术治疗老年恶性肿瘤患者苏醒期质量及免疫功能的影响。方法 选择择期行腔镜手术治疗的老年恶性肿瘤患者90例,随机均分为3组:对照组(C组)、体温保护组(T组)和体温保护联合右美托咪定组(T-D组),每组30例。C组常规体温保护,T组和T-D组综合体温保护;T-D组麻醉诱导前10 min泵注右美托咪定0.5 μg/kg。记录3组患者麻醉诱导开始时(T0)、手术开始30 min(T1)、60 min(T2)、90 min(T3)、120 min(T4)以及手术结束时(T5)的鼻咽温度;于T0、术后2 h(T6)、24 h(T7)和48 h(T8)时抽取静脉血标本,测定T淋巴细胞亚群(CD3+、CD4+和CD8+)和自然杀伤细胞(NK cell)水平;记录患者术中麻醉药物用量及苏醒期质量指标。结果 与T0比较,C组T2~T5时点鼻咽温度均明显降低(P < 0.05);与C组比较,T组和T-D组T2~T5时点鼻咽温度明显升高(P < 0.05)。与T0时点比较,C组、T组和T-D组T6、T7和T8时点CD3+和NK cell活性均明显降低(P < 0.05);C组在T6、T7和T8时点,T组和T-D组在T6和T7时点,CD4+活性均明显降低(P < 0.05)。与C组比较,T组和T-D组T6和T7时点CD3+细胞活性均明显升高(P < 0.05);T组在T7时点,T-D组在T6和T7时点,CD4+细胞活性均明显升高(P < 0.05);T组在T7时点,T-D组在T6、T7和T8时点,NK cell活性均明显升高(P < 0.05)。结论 采用体温保护措施联合右美托咪定能够维持老年恶性肿瘤患者的体温稳定,减少围手术期意外低体温(IPH)的发生,并有效提高患者苏醒期质量,减轻免疫抑制程度,加速患者早期恢复。 相似文献
9.
10.
Mette Nissen Tiina‐Mari Ikheimo Jukka Huttunen Ville Leinonen Henna‐Kaisa Jyrkknen Mikael von und zu Fraunberg 《Neuromodulation》2021,24(1):102-111
ObjectiveSpinal cord stimulation (SCS) is an effective treatment in failed back surgery syndrome (FBSS). We studied the effect of preimplantation opioid use on SCS outcome and the effect of SCS on opioid use during a two-year follow-up period.Materials and methodsThe study cohort included 211 consecutive FBSS patients who underwent an SCS trial from January 1997 to March 2014. Participants were divided into groups, which were as follows: 1) SCS trial only (n = 47), 2) successful SCS (implanted and in use throughout the two-year follow-up period, n = 131), and 3) unsuccessful SCS (implanted but later explanted or revised due to inadequate pain relief, n = 29). Patients who underwent explantation for other reasons (n = 4) were excluded. Opioid purchase data from January 1995 to March 2016 were retrieved from national registries.ResultsHigher preimplantation opioid doses associated with unsuccessful SCS (ROC: AUC = 0.66, p = 0.009), with 35 morphine milligram equivalents (MME)/day as the optimal cutoff value. All opioids were discontinued in 23% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.004). Strong opioids were discontinued in 39% of patients with successful SCS, but in none of the patients with unsuccessful SCS (p = 0.04). Mean opioid dose escalated from 18 ± 4 MME/day to 36 ± 6 MME/day with successful SCS and from 22 ± 8 MME/day to 82 ± 21 MME/day with unsuccessful SCS (p < 0.001).ConclusionsHigher preimplantation opioid doses were associated with SCS failure, suggesting the need for opioid tapering before implantation. With continuous SCS therapy and no explantation or revision due to inadequate pain relief, 39% of FBSS patients discontinued strong opioids, and 23% discontinued all opioids. This indicates that SCS should be considered before detrimental dose escalation. 相似文献